i-SENS, Inc. (KOSDAQ:099190)
15,420
+320 (2.12%)
Apr 1, 2025, 3:30 PM KST
i-SENS Revenue
In the year 2024, i-SENS had annual revenue of 291.14B KRW with 9.81% growth. i-SENS had revenue of 81.31B in the quarter ending December 31, 2024, with 8.50% growth.
Revenue
291.14B
Revenue Growth
+9.81%
P/S Ratio
1.46
Revenue / Employee
344.54M
Employees
845
Market Cap
426.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 291.14B | 26.02B | 9.81% |
Dec 31, 2023 | 265.12B | 283.13M | 0.11% |
Dec 31, 2022 | 264.84B | 31.90B | 13.70% |
Dec 31, 2021 | 232.93B | 29.23B | 14.35% |
Dec 31, 2020 | 203.71B | 13.86B | 7.30% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |